Sumitomo Pharma Co., Ltd.

SMDPY · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$23,116$29,047$143,478$202,984
Short-Term Investments$16,840$7,085$20,174$35,596
Receivables$74,840$81,023$95,908$151,407
Inventory$94,222$115,350$94,405$99,021
Other Curr. Assets$44,150$37,064$27,895$10,513
Total Curr. Assets$253,168$269,569$381,860$499,521
Property Plant & Equip (Net)$46,648$57,895$58,909$64,091
Goodwill$197,406$199,783$209,415$195,144
Intangibles$172,509$195,652$329,314$398,692
Long-Term Investments$72,339$161,711$144,399$127,909
Tax Assets$534$0$10,845$22,650
Other NC Assets$0$22,896$0$0
Total NC Assets$489,436$637,937$752,882$808,486
Other Assets$0$0$0$0
Total Assets$742,604$907,506$1,134,742$1,308,007
Liabilities
Payables$38,544$38,544$13,403$22,455
Short-Term Debt$46,440$289,298$95,248$30,548
Tax Payable$1,577$1,348$24,053$7,583
Deferred Revenue$0$0$151,952$140,034
Other Curr. Liab.$154,042$158,685$88,038$77,753
Total Curr. Liab.$240,603$515,474$372,694$278,373
LT Debt$258,982$138,566$251,124$253,996
Deferred Rev, NC$0$0$16,877$27,932
Deferred Tax Liab, NC$26,550$38,211$36,505$26,550
Other NC Liab.$46,990$59,119$50,760$47,587
Total NC Liab.$332,522$235,896$355,266$356,065
Other Liabilities$0$0$0$0
Cap. Leases$0$8,980$11,656$15,496
Total Liabilities$573,125$751,370$727,960$634,438
Equity
Pref Stock$0$0$0$0
Common Stock$22,400$22,400$22,400$22,400
Retained Earnings$46,784-$22,665$280,999$514,210
AOCI$100,977$157,010$104,032$55,234
Other Equity-$682-$682-$682$16,044
Total Equity$169,479$156,063$406,749$607,888
Supplemental Information
Minority Interest$0$73$33$65,681
Total Liab. & Tot. Equity$742,604$907,506$1,134,742$1,308,007
Net Debt$282,306$398,817$202,894$81,560